Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 5:08 PM ET

Health Care Technology

Company Overview of Rennova Health, Inc.

Company Overview

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. It offers diagnostic laboratory testing and analytics for precision medicine, specialized and streamlined electronic health records (EHRs), and other essential software services; and medical billing and financial services for enhanced revenue cycle management. The company’s diagnostics solutions feature a range of toxicology, clinical, and esoteric lab services, including neurotransmitter testing. It also offers an integrated medical billing solution that enhances revenue cycle management; and healthcare software solutions, such as technologies and specialized applications for EHRs, a laborat...

400 South Australian Avenue

Suite 800

West Palm Beach, FL 33401

United States

Founded in 2005

170 Employees



Key Executives for Rennova Health, Inc.

Chief Executive Officer, President and Director
Age: 46
Compensation as of Fiscal Year 2014.

Rennova Health, Inc. Key Developments

Rennova Health Seeks Acquisitions

Rennova Health, Inc. (NasdaqCM:RNVA) will use the proceeds of the follow-on equity offering for working capital and general corporate purposes, including paying for possible acquisitions or expansion of our business.

Samuel R. Mitchell Resigns as Chief Operating Officer of Rennova Health, Inc

On November 12, 2015, Rennova Health, Inc. announced that Samuel R. Mitchell, Chief Operating Officer of the company, provided Mr. Mitchell the required 60-day notice of the termination of his agreement without cause. Mr. Mitchell’s last day with the company will be January 11, 2016.

Medytox Announces Management Changes

In connection with the Merger, each of the directors of Medytox immediately prior to the effective time of the Merger, except for Seamus Lagan, voluntarily resigned from the board of directors of Medytox and Mr. Lagan and Jason Adams became the sole directors of Medytox. Pursuant to the Merger Agreement and at the effective time of the Merger, the sole officers of Medytox are Mr. Lagan, Chief Executive Officer and President, Jason Adams, Chief Financial Officer, Jeffrey Wadman, Treasurer, and Sebastien Sainsbury, Secretary.

Similar Private Companies By Industry

Company Name Region
HealthInterlink, LLC United States
allyDVM, Inc. United States
MRO Corporation United States
Real Time Enterprises, Inc. United States
Dynamic Health Strategies, Inc. United States

Recent Private Companies Transactions

Private Placement
May 31, 2015
January 22, 2015
CollabRx, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rennova Health, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at